Cargando…
Interleukin-6 as a potential biomarker of COVID-19 progression
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Masson SAS.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129451/ https://www.ncbi.nlm.nih.gov/pubmed/32259560 http://dx.doi.org/10.1016/j.medmal.2020.04.002 |
| _version_ | 1783516788688945152 |
|---|---|
| author | Ulhaq, Zulvikar Syambani Soraya, Gita Vita |
| author_facet | Ulhaq, Zulvikar Syambani Soraya, Gita Vita |
| author_sort | Ulhaq, Zulvikar Syambani |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7129451 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Masson SAS. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71294512020-04-08 Interleukin-6 as a potential biomarker of COVID-19 progression Ulhaq, Zulvikar Syambani Soraya, Gita Vita Med Mal Infect Letter to the Editor Elsevier Masson SAS. 2020-06 2020-04-04 /pmc/articles/PMC7129451/ /pubmed/32259560 http://dx.doi.org/10.1016/j.medmal.2020.04.002 Text en © 2020 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Ulhaq, Zulvikar Syambani Soraya, Gita Vita Interleukin-6 as a potential biomarker of COVID-19 progression |
| title | Interleukin-6 as a potential biomarker of COVID-19 progression |
| title_full | Interleukin-6 as a potential biomarker of COVID-19 progression |
| title_fullStr | Interleukin-6 as a potential biomarker of COVID-19 progression |
| title_full_unstemmed | Interleukin-6 as a potential biomarker of COVID-19 progression |
| title_short | Interleukin-6 as a potential biomarker of COVID-19 progression |
| title_sort | interleukin-6 as a potential biomarker of covid-19 progression |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129451/ https://www.ncbi.nlm.nih.gov/pubmed/32259560 http://dx.doi.org/10.1016/j.medmal.2020.04.002 |
| work_keys_str_mv | AT ulhaqzulvikarsyambani interleukin6asapotentialbiomarkerofcovid19progression AT sorayagitavita interleukin6asapotentialbiomarkerofcovid19progression |